Managing Scalp Psoriasis Through Ayurvedic Therapies: A Case Report
Nagpure D, Asutkar S, Yadav P, Patil S (2025) · Alternative Therapies in Health and Medicine · n=1
Detalle de evidencia de RCTReferencia del ensayo
Perfil del estudio
- Diseño
- single-patient case report (35-year-old male with chronic scalp psoriasis, Mahatma Gandhi Ayurvedic College Hospital & Research Center, Salod-H, Wardha, India)
- Tamaño de la muestra (n)
- 1
- Intervención
- Multi-modal Ayurvedic protocol: Panchakarma including Vamana (therapeutic emesis), 777 oil topical, Psora soap, Panchatikta Ghrita Guggulu, Sut Shekhar Ras, weekly Leech therapy (Raktamokshana) for 1 month, plus lifestyle modifications
- Comparador
- Conventional psoriasis therapies (prior treatments failed)
- Punto final primario
- Symptom relief, scaling reduction, erythema improvement, lesion thickness change
- Resultado primario
- Significant relief from itching, scaling, erythema, and lesion thickness; improved scalp texture and absence of flare-ups at follow-up; no adverse effects reported
- Duración del seguimiento
- 1 month treatment + follow-up assessment
- PMID
- 40492749
Hallazgos clave
- Multi-modal Ayurvedic protocol with leech therapy adjunct
- Significant symptom improvement: itching, scaling, erythema, thickness
- No flare-ups at follow-up
- No adverse effects reported
- Authors call for further clinical trials
Limitaciones
- Single case - cannot establish efficacy
- Multi-component intervention prevents isolation of leech contribution
- Subjective outcome assessment
- 1-month follow-up insufficient for chronic disease relapse rate
- Publication bias toward successful Ayurvedic outcomes
Implicaciones clínicas
Nagpure 2025 provides hypothesis-generating evidence for leech therapy as part of multi-modal Ayurvedic protocol in recalcitrant scalp psoriasis. For US clinicians under K040187, this case extends device application into dermatologic conditions beyond the established flap/replant indication. The multi-component intervention prevents isolated efficacy attribution but motivates controlled adjunct trials.